News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

22

2025

-

07

Set the course and break new ground! Linuo Pharmaceutical holds the 2025 mid-year performance review meeting to clarify direction and sprint towards annual goals!

Classification:

行业新闻

Corporate News


The journey spans thousands of miles with a strong wind; the heavy responsibility of a thousand pounds sets off again! 7 Month 20 Day, Linuo Pharmaceutical grandly held 2025 the mid-year management cadre report meeting of the year, comprehensively summarizing the business achievements of the first half of the year, deeply analyzing the development situation, clarifying the strategic direction for the second half of the year, and mobilizing all cadres and staff to anchor goals, overcome difficulties, and sprint towards the annual task targets with firmer determination and stronger measures.

Senior management of the company, heads of various business sectors and functional departments attended the meeting to jointly draw a new blueprint for high-quality development.

 

At the beginning of the conference, all participants sang the "Linuo Song" together and recited the corporate culture, demonstrating the spirited and upward spirit of Linuo people. Then, the company management gave speeches one after another to open the conference. Next, the heads of various departments reported their work in turn, with the Product Development Center, Lean Operation Center, Finance Center, Human Resources Center and other departments reporting on 2025 the summary of work in the first half of the year, key work plans for the second half of the year, and cost reduction and efficiency improvement.

 

Gao Chunpo, Chairman and CEO of Keyuan Pharmaceutical, Li Hongfu, Chairman of Linuo Pharmaceutical, and Huang Fangsheng, President, gave in-depth comments and analysis on the reports from various departments, providing valuable suggestions for subsequent work.

 

 

The conference pointed out that facing the complex and ever-changing pharmaceutical market situation, the enterprise must always maintain strategic focus, accurately exert efforts in policy interpretation and market judgment to ensure the development direction does not deviate; continuously deepen core businesses such as product research and development, intelligent manufacturing, and quality management, using AI technology to improve quality and efficiency, laying a solid foundation for market competition; strengthen internal collaboration and linkage, break down departmental barriers, and form an efficient combat system that connects vertically and coordinates horizontally to respond to external challenges with overall synergy.

The successful convening of this conference unified thoughts, gathered consensus, pointed out measures, and boosted morale, injecting a "strong tonic" for the company's goal achievement in the second half of the year. All employees will work with greater enthusiasm, implement tasks with a more pragmatic style, tackle difficulties with a more vigorous fighting spirit, shine in their respective positions, and sound the charge for achieving annual goals with practical work and responsibility!